American Journal of Cardiovascular Drugs · 2024 · 34 citations · 69 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyClinical Decision SupportCardiac MedicationsCardiac PharmacotherapyGoal-directed TherapyHeart FailureHeart Failure NursingHeart Failure PharmacotherapyChronic Heart Failure CareChronic Heart Failure ManagementCongestive Heart Failure ManagementGuideline-based TherapyGuideline-directed Medical TherapyGuideline-directed TherapyNurse PractitionersTitration Algorithms
The delayed titration of guideline-directed drug therapy (GDMT) is a complex event influenced by multiple factors that often result in poor prognosis for patients with heart failure (HF). Individualized adjustments in GDMT titration may be necessary based on patient characteristics, and every clinician is responsible for promptly initiating GDMT and titrating it appropriately within the patient's tolerance range. This review examines the current challenges in GDMT implementation and scrutinizes titration considerations within distinct subsets of HF patients, with the overarching goal of enhancing the adoption and effectiveness of GDMT. The authors also underscore the significance of establishing a novel management strategy that integrates cardiologists, nurse practitioners, pharmacists, and patients as a unified team that can contribute to the improved promotion and implementation of GDMT.
69
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres et al. · European Heart Journal · 2020 · 9.9K citations · Full text
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler et al. · New England Journal of Medicine · 2020 · 5K citations · Full text
Medicine, Cardiology, Pharmacology +17
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg, Michel Komajda, Michael Böhm et al. · The Lancet · 2010 · 2.6K citations · Full text
Medicine, Cardiology, Pharmacology +11